CBD Isolate

DRUG3 trials

Sponsors

University of Texas at Austin, University of Manitoba

Conditions

Alcohol AbuseAngerAnxiety DepressionDrug Resistant EpilepsyPost Traumatic Stress DisorderSleep DisturbanceStress ReactionSubstance Abuse

Phase 2

Use of CBD Oil in the Treatment of Posttraumatic Stress Disorder

SuspendedNCT04197102

University of Texas at AustinPost Traumatic Stress Disorder

Start: 2020-01-15End: 2025-05-31Target: 150Updated: 2023-11-22

CBD Oil for Reducing Emotional Impact of COVID-19

SuspendedNCT04603781

University of Texas at AustinAlcohol Abuse, Anger, Anxiety Depression +3

Start: 2020-12-04End: 2023-12-31Target: 200Updated: 2023-11-22

CANnabinoids for Drug Resistant Epilepsy (DRE) in Adults and Children

Not yet recruitingNCT07023744

University of ManitobaDrug Resistant Epilepsy

Start: 2026-07-27End: 2028-03-31Target: 90Updated: 2026-06-11

Related Papers

Use of Cannabidiol (CBD) oil in the treatment of PTSD: Study design and rationale for a placebo-controlled randomized clinical trial.

2022-09-229 citations